Financials

  • Market Capitalization 3.87 B
  • Employee 145
  • Founded 2015
  • CEO N/A
  • Website www.ideayabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00CTZ4D83
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-19.51
Rapporto prezzo/fatturato
14.28

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1518
TNGX
Tango Therapeutics, Inc. - Common Stock
23.34 USD-7.67%-1.10%-15.19%+253.10%3.94 B USD
1532
AMLX
Amylyx Pharmaceuticals, Inc. - Common Stock
34.74 USD-6.56%-10.09%+68.72%+277.61%3.87 B USD
1541
DNLI
Denali Therapeutics Inc. - Common Stock
24.00 USD-2.72%-3.54%-1.40%+48.42%3.84 B USD
1544
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
11.29 USD-0.79%-1.48%+12.90%+78.92%3.82 B USD

Notizie